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A B S T R A C T
In a recent machine learning study classifying “brain age” based on cross-sectional neuroanatomical data,
clinical high-risk (CHR) individuals were observed to show deviation from the normal neuromaturational pat-
tern, which in turn was predictive of greater risk of conversion to psychosis and a pattern of stably poor
functional outcome. These eﬀects were unique to cases who were between 12 and 17 years of age when their
prodromal and psychotic symptoms began, suggesting that neuroanatomical deviance observable at the point of
ascertainment of a CHR syndrome marks risk for an early onset form of psychosis. In the present study, we
sought to clarify the pattern of neuroanatomical deviance linked to this “early onset” form of psychosis and
whether this deviance is associated with poorer premorbid functioning. T1 MRI scans from 378 CHR individuals
and 190 healthy controls (HC) from the North American Prodrome Longitudinal Study (NAPLS2) were analyzed.
Widespread smaller cortical volume was observed among CHR individuals compared with HC at baseline eva-
luation, particularly among the younger group (i.e., those who were 12 to 17 years of age). Moreover, the
younger CHR individuals who converted or presented worsened clinical symptoms at follow-up (within 2 years)
exhibited smaller surface area in rostral anterior cingulate, lateral and medial prefrontal regions, and para-
hippocampal gyrus relative to the younger CHR individuals who remitted or presented a stable pattern of
prodromal symptoms at follow-up. In turn, poorer premorbid functioning in childhood was associated with
smaller surface area in medial orbitofrontal, lateral frontal, rostral anterior cingulate, precuneus, and temporal
regions. Together with our prior report, these results are consistent with the view that neuroanatomical deviance
manifesting in early adolescence marks vulnerability to a form of psychosis presenting with poor premorbid
adjustment, an earlier age of onset (generally prior to the age of 18 years), and poor long-term outcome.
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1. Introduction
Elucidation of biomarkers predictive of schizophrenia and other
psychotic disorders is a high priority for the ﬁeld. Neuroanatomical
deviance, as assessed using quantitative metrics derived from magnetic
resonance imaging (MRI) scans, has been suggested as potentially re-
levant to this goal. Several studies have observed a steeper rate of
cortical thinning, particularly in heteromodal association regions,
among clinical high-risk individuals (CHR) who convert to psychosis
compared with those who do not convert and healthy controls
(Borgwardt et al., 2008; Cannon et al., 2015; Chung et al., 2018; Pan-
telis, 2003; Sun et al., 2009, Takahashi et al., 2009). However, prior
studies have obtained conﬂicting results as to whether individuals at
CHR with poorer clinical and functional outcomes manifest measurable
neuroanatomical deviance at the time of baseline evaluation (i.e. when
help-seeking individuals were initially evaluated and met criteria for a
psychosis-risk syndrome), as would be necessary if these measures are
to have utility as predictive biomarkers (Borgwardt et al., 2007; Fusar-
Poli et al., 2011; Mechelli et al., 2011; Pantelis et al., 2003; Takahashi
et al., 2009; Velakoulis et al., 2006).
The wide age range of CHR samples (typically, 12–35 years) re-
presents a major challenge for elucidation of neuroanatomical markers
predictive of psychosis, given that deviance on such measures is only
ascertainable with respect to age-appropriate norms, and there are
marked developmental changes in brain structure across this age span
(Brown et al., 2012; Gogtay et al., 2004; Tamnes et al., 2017). Further,
given the heterogeneity in the timing of potentially relevant risk ex-
posures and age at onset of prodromal symptoms and subsequent psy-
chosis, the degree to which CHR cases manifest neuroanatomical de-
viance may well depend on their age at evaluation. Other factors that
likely contribute to the inconsistent ﬁndings of prior MRI studies of
CHR samples include the use of relatively small sample sizes and un-
even application of statistical controls for multiple testing.
To overcome these limitations, we recently performed a machine-
learning analysis of “brain age” using MRI measures in the North
American Prodrome Longitudinal Study (NAPLS 2) sample (Chung
et al., 2018). A neuroanatomical-based age prediction model was de-
veloped using a supervised machine learning technique with T1 MRI
scans from the Pediatric Imaging, Neurocognition, and Genetics (PING)
study and then applied to NAPLS2 scans for external validation and
clinical application (Brown et al., 2012; Chung et al., 2018; Jernigan
et al., 2016). The PING-derived model accurately predicted NAPLS
healthy control subjects' chronological ages, providing evidence of in-
dependent, external validation. CHR individuals ascertained at younger
ages (i.e., 12 to 17 years) were observed to show deviance from the
normal neuromaturational pattern (i.e., a gap between “brain age” and
chronological age), which in turn was associated with greater risk of
conversion to psychosis and a pattern of stably poor functional out-
come. In contrast, individuals who were 18 years of age or older showed
age-normative neuroanatomical proﬁles at ascertainment (i.e., no gap
between “brain age” and chronological age). A reevaluation of our prior
ﬁndings showing a steeper rate of cortical thinning over time among
CHR cases who converted to psychosis revealed that this eﬀect was
unique to the cases who were 18 years or older at ascertainment and did
not apply to the younger cases (Cannon et al., 2015; Chung et al.,
2018). This pattern is consistent with the view that neuroanatomical
deviance manifesting in early adolescence marks vulnerability to a form
of psychosis with an insidious onset and debilitating course of illness,
while accelerated cortical thinning marks vulnerability to a more acute
onset form of illness that does not manifest until late adolescence and
early adulthood.
In the present study, we address two additional issues concerning
the “early onset” form of psychosis. First, we aim to determine whether
neuroanatomical deviance in early adolescence is associated with
poorer premorbid functioning during childhood, as would be expected
if this pattern is associated with a more insidious onset. Second, we aim
to clarify whether the neuroanatomical deviance associated with onset
of psychosis in early adolescence is distributed in brain regions pre-
viously linked to schizophrenia, including superior, medial, and dor-
solateral prefrontal cortex, anterior cingulate, superior temporal cortex,
and parahippocampal gyrus (Borgwardt et al., 2007; Fusar-Poli et al.,
2011; Mechelli et al., 2011; Pantelis et al., 2003). Although the “brain
age” approach can quantitatively assess deviations in brain maturation
at the single subject level, a feature that makes it particularly useful for
prediction purposes, the anatomical features selected by the algorithm
are not necessarily indicative of risk for a particular disorder (Chung
et al., 2018). By design, the ﬁtted model parameters are data-driven,
characterizing the regularized maturation pattern among brain struc-
tures that tracks with variations in chronological age among typically
developing individuals. In other words, this “brain age” composite
metric is not optimized for detecting schizophrenia risk per se and
would presumably be sensitive to any condition in which cases deviate
from the normal pattern of age-related neuroanatomical change during
childhood/adolescence. Machine-learning algorithms trained to predict
psychosis as an outcome could potentially yield a psychosis-speciﬁc
pattern of neuroanatomical deviance (Koutsouleris et al., 2009). How-
ever, in the NAPLS2 study, such models were found to perform poorly
compared with the “brain age” classiﬁer, probably because the struc-
tural brain changes related to psychosis onset occur against the back-
drop of the gradual gray matter decline that is part of normative ado-
lescent brain development and because heterogeneity in the pathways
leading to full psychosis works against the accuracy of machine
learning algorithms trained on an outcome that treats all converters as
exemplars of a unitary outcome class (Chung et al., 2018).
Here we report the results of group contrasts of the baseline MRI
data according to 2-year clinical outcome in the same NAPLS2 sample
that was used in the brain age prediction study. This analysis provides
added value to the “brain age” prediction results in that it provides a
more direct test of neuroanatomical changes associated with risk for
psychosis and whether these eﬀects are moderated by age at ascer-
tainment and associated with poor premorbid adjustment. Based on the
foregoing, we hypothesized that CHR individuals who are 17 years of
age or younger would show smaller cortical volumes in dorsal lateral
prefrontal cortex, medial prefrontal cortex, superior temporal gyrus,
and parahippocampal areas. We also predicted that the younger CHR
adolescents with persisting or worsening prodromal symptoms would
show a greater degree of neuroanatomical deviance at baseline than
those who are on the course of remission. We further hypothesized that
the preexisting neuroanatomical deﬁcits among younger CHR adoles-
cents are associated with poorer premorbid functioning in childhood.
2. Material and methods
2.1. Participants
Participants were recruited through the NAPLS2 consortium, con-
sisting of eight sites (UCLA, Emory, Beth Israel Deaconess Medical
Center, Zucker Hillside Hospital, UNC, UCSD, Calgary, Yale) studying
the psychosis prodrome in North America (Addington et al., 2012). The
study protocols and informed consent forms for NAPLS2 were approved
by the IRBs of all sites, and all procedures comply with the ethical
standards of the relevant committees. The CHR cases met the Criteria of
Prodromal Syndromes (COPS) based on the Structured Interview for
Prodromal Syndromes (SIPS) for the presence of one or more of the
three psychosis-risk syndromes: Brief Intermittent Psychotic Syndrome,
Attenuated Positive Symptom Syndrome, and genetic Risk and Dete-
rioration Syndrome (McGlashan et al., 2010).
Participants who meet criteria for attenuated psychotic symptom
present onset or worsening of at attenuated positive symptoms in the
past 12months in at least one of the following ﬁve symptom domains:
unusual thought content, suspicion/paranoia, grandiosity, perceptual
anomalies, and disorganized communication. Participants also qualiﬁed
Y. Chung, et al. NeuroImage: Clinical 23 (2019) 101862
2
for a prodromal syndrome if they began displaying (in the past
3months) brief intermittent positive psychotic symptoms below the
threshold required for a DSM-IV axis I psychotic disorder diagnosis
(First et al., 1995), or if they possessed a genetic risk for psychosis and
displayed deterioration in functioning amounting to a 30% decline in
their score on the Global Assessment of Functioning (GAF) scale in the
past 12months. Genetic risk was deﬁned as a family history of psy-
chosis in ﬁrst-degree relatives or a diagnosis of schizotypal personality
disorder. All North American Prodrome Longitudinal Study sites de-
monstrated good reliability employing the prodromal criteria (kappa
range: 0.80–1.00 across sites) (Miller et al., 2002).
Subjects included in this report are those with MRI scans at baseline
and with the latest follow-up SIPS assessment within 24months or at
the point of conversion to psychosis. Healthy control individuals were
excluded if they met criteria for a psychotic disorder or Cluster A per-
sonality disorder, or showed prodromal signs, had a ﬁrst-degree relative
with a current or past psychotic disorder, or were on any psychotropic
medication. As general criteria, individuals with past or current psy-
chotic disorder, estimated IQ < 70, a central nervous system disorder,
or substance dependence were excluded. Demographic characteristics
of the three groups based on clinical outcome are shown in Table 1.
2.2. Deﬁning outcome of CHR syndromes based on current clinical state
In CHR studies with longitudinal evaluation using the SIPS, the
clinical outcome of interest has generally been based on classiﬁcation of
converters (CHReC) versus non-converters (CHR-NC). However, given
that only about 22% of the CHR individuals convert to psychosis within
1 year (Fusar-Poli et al., 2012), this approach results in a relatively
small number of subjects in the CHR-C group (and an imbalance com-
pared with the CHR-NC group for estimating means and variances),
which signiﬁcantly attenuates statistical power when performing group
based statistics. In addition, while some of the non-converters show
signs of remission at follow-up evaluation, some continue to exhibit
sub-clinical symptoms of psychosis that persist or worsen over time
(Addington et al., 2011). Therefore, in this study, we deﬁned clinical
outcome based on Current Clinical State criteria in the SIPS, which
classiﬁes clinical status by evaluating the course of symptoms in the
month prior from the point of assessment (Woods et al., 2014). CHR
individuals with partially (“symptomatic”) or fully remitted prodromal
symptoms at follow-up were grouped together and labeled as the “CHR-
Stable/Remitted” group, whereas CHR individuals with persisting or
progressing severity of prodromal symptoms or those who converted to
psychosis were grouped together as the “CHR-Converted/Decline”
group. This classiﬁcation created a more balanced sample sizes and
Table 1
Demographic characteristics of participants.
Age: 12–17 Age: 18–35
HC
N=52
CHR-Stable/Remitted
N=87
CHR-Decline
N=59
Statistical Test
(2 tailed)/
P Value
HC
N=137
CHR-Stable/Remitted
N=131
CHR-Decline
N=100
Statistical Test (2
tailed)/
P Value
Age, mean(SD), y 14.99(1.43) 15.34(1.29) 15.26(1.15) F= 1.23,
P=.29
22.58(2.75) 22.33(2.53) 21.62(2.76) F= 7.95,
P < .001e
Male sex, No. (%) 37(69.8) 48(54.5) 29 (0.49) χ2=5.95,
P=.050
61(44.5) 84(64.1) 66(66) χ2=14.73,
P < .001
White /ethnicity, No. (%) 32(60.3) 47(53.4) 39(66.1) χ2=2.03,
P=.362
75(54.7) 82(62.6) 61(61) χ2=1.88,
P= .36
Hispanic or Latino
/ethnicity, No. (%)
9 22 12 χ2=0.23,
P=.88
22(16.0) 16(12.2) 16(16) χ2=0.98,
P= .61
Education level, mean (SD),
y
8.35(1.45) 8.55(1.54) 8.62(1.19) F= 16.02,
P < .001a
14.78(2.24) 13.38(1.82) 13.24(1.83) F= 23.26,
P < .001e
Paternal education score,
mean (SD)g
6.52(1.70) 5.69(1.57) 6.20(1.60) F= 4.40,
P=0.013b
6.57(1.59) 6.60(1.65) 6.38(1.83) F= 0.56,
P= .57
Maternal education score,
mean (SD)g
7.01(1.52) 6.31(1.62) 6.36(1.73) F= 3.35,
P=0.037b
6.67(1.46) 6.45(1.52) 6.45(1.71) F= 0.87,
P= .41
Taking antipsychotics, No.
(%) h, i
0(0) 17(33.3) 10(22.2) χ2=0.91,
P=.33
0(0) 15(13.5) 20(22.9) χ2=3.00,
P= .08
Scale of Prodromal Symptoms score, mean (SD)
Positive 0.96(1.37) 11.09(3.99) 11.84(3.22) F= 197.5
P < .001d
0.79(1.44) 12.0(3.86) 12.67(4.33) F= 508.8
P < .001d
Negative 1.5(2.41) 11.86(6.14) 10.64(5.27) F= 71.63
P < .001 d
1.25(1.96) 11.93(1.64) 12.58(6.59) F= 189.6
P < .001d
Disorganization 0.67(1.18) 4.44(2.63) 5.41(3.48) F= 49.59
P < .001 d
0.50(0.92) 5.01(3.16) 6.08(3.70) F= 144.1
P < .001f
General 1.12(2.23) 8.61(4.24) 9.05(4.61) F= 72.28
P < .001 d
1.33(2.11) 8.94(4.56) 9.12(3.85) F= 192
P < 0.001d
PAS Total: Childhood 0.11(0.09) 0.26(0.18) 0.29(0.17) F= 22.00
P < 0.001 d
0.12(0.11) 0.23(0.17) 0.22(0.16) F= 21.95
P < 0.001d
GAF Score at Baseline 84.15(11.74) 50.62(11.57) 48.86(10.97) F= 172.30
P < 0.001 d
84.84(9.41) 48.60(12.19) 47.29(10.01) F= 515.2
P < 0.001d
Post hoc Tukey Test: aHC < CHR-Stable/Remitted, CHR-Decline, bCHR-Stable/Remitted<HC, CHR-Decline, cCHR-Stable/Remitted, CHR-Decline<HC,
dHC < CHR-Stable/Remitted, CHR-Converted/Decline, eCHR-Stable/Remitted, CHR-Decline<HC, fHC < CHR-Stable/Remitted<CHR-Decline.
Abbreviations: CHR, clinically high-risk individuals; GAF, Global Assessment of Functioning; HC, healthy controls; NA, not applicable; PAS, premorbid adjustment
scale.
g Parental education scored as follows: 1, no schooling; 2, some primary school; 3, completed primary school; 4, some high school; 5, completed high school; 6, some
college, technical school, or undergraduate education; 7, completed college, technical school, or undergraduate education; 8, some graduate or professional school;
and 9, completed graduate or professional school.
h Because this was a naturalistic study, individuals were treated in their respective communities according to prevailing standards and the judgment of the treating
clinicians, who were often primary care physicians rather than psychiatrists.
i χ2 Test performed within CHR group.
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variability in each group (CHR-Stable/Remitted: N=219, CHR-Con-
verted/Decline: N=159).
2.3. MRI data acquisition
Five sites (University of California, Los Angeles, Emory University,
Harvard University, University of North Carolina, and Yale University)
operated Siemens scanners and three sites operated GE scanners
(Zucker Hillside Hospital, University of California, San Diego,
University of Calgary). Magnetic ﬁeld strength for all scanners were 3
Tesla. Siemens sites used a 12-channel head coil and the GE sites used
an 8-channel head coil. Sequence parameters were optimized for each
scanner manufacturer, software version and coil conﬁguration ac-
cording to the ADNI protocol (http://adni.loni.ucla.edu/research/
protocols/mri-protocols/) (Mueller et al., 2005). At all sites, scans
were acquired in the sagittal plane with a 1mm×1mm in-plane re-
solution and 1.2 mm slice thickness. Siemens scanners used an MPRAGE
sequence with a 256 (axial) x 240 (sagittal) x 176 (coronal) mm ﬁeld of
view, TR/TE/TI52300/2.91/900 ms and a 9 degree ﬂip angle, while GE
scanners used an IR-SPGR sequence (efgre3d_cs) with a 26 cm ﬁeld of
view, TR/TE/TI57.0/minimum full/ 400ms and an 8 ﬂip angle
(Cannon et al., 2013).
2.4. Image processing
Automated surface based cortical reconstruction, cortical parcella-
tion and subcortical segmentation were performed using the Freesurfer
software suite version 5.3 (http:// surfer.nmr.mgh.harvard.edu/) (Dale
et al., 1999; Fischl, 2004; Fischl and Dale, 2000; Fischl et al., 2002;
Fischl et al., 1999). Regional parcels for gray matter volume, cortical
thickness and surface area were extracted using a gyral and sulcal
pattern based Desikan atlas with 34 parcels in each hemisphere
(Desikan et al., 2006).
2.5. Adjusting for scanner-speciﬁc oﬀsets
Although the scanners used in this study were all 3 Tesla systems
with standardized pulse sequence parameters across all sites, scanner
related noise that is speciﬁc to manufactures, models, coil conﬁgura-
tion, ﬁeld inhomogeneity and other idiosyncratic signatures that are
unique to each scanner could still contribute noise to the anatomical
measurements (Cannon et al., 2013; Dewey et al., 2010; Nugent et al.,
2013; Schnack et al., 2010). Therefore, we tried to further improve
between-site reliability by modeling scanner related variance in the
regression of age among typically developing adolescents and young
adults (i.e., NAPLS2 healthy controls) with a linear mixed eﬀects model.
Age, sex, and ICV were treated as ﬁxed factors and scanner ID was
treated as a random intercept for each neuroanatomical measure. After
ﬁtting the model, random intercept parameters ﬁtted for each scanner
were derived to adjust the diﬀering intercepts of age regressions across
scanners for both healthy controls and CHR cases. This approach ca-
pitalizes on an assumption that there is a true “ﬁxed” slope of age in a
typically developing population for a given neuroanatomical region; the
assumption is widely supported by previous studies that have con-
sistently shown that the shape of the non-linear age trajectories, be-
tween childhood and early adulthood, for a given structural brain
measure are remarkably parallel across multiple independent datasets
(Gogtay et al., 2004; Tamnes et al., 2017; Tamnes et al., 2010). This
pattern was also observed in our dataset when age-trajectories were
modeled separately by each scanner (see Fig. 1). For the purpose of
estimating the variance of scanner as a random eﬀect, the age trajec-
tories were modeled only among healthy controls, as the age-related
variance in the CHR group would be more variable due to the hetero-
geneity in the underlying disease process. Although it is well known
that the shape of the developmental trajectories for neuroanatomical
measures is best characterized as a non-linear process (Fjell et al.,
2010), ﬁtting a linear model is appropriate to prevent overﬁtting of the
data, especially for sites with small sample size. MRI scanners that as-
sessed less than ten control subjects were dropped from this analysis
because scanner related variance could not be reliably modeled. For
this reason, a total of 20 controls and 67 CHR cases (6 of whom were
converters) were excluded from the analysis.
2.6. Human traveling subjects
MRI scanner reliability and the eﬀectiveness of the statistical cor-
rection method implemented in this study to reduce scanner related
variance were assessed using human traveling subjects data. Detailed
information about the human traveling subjects, scanning equipment,
and prior reliability study results are documented in previous publica-
tions (Cannon et al., 2013). Brieﬂy, each of these sites recruited one
healthy subject (4 males, 4 females) between the ages of 20 and 31
(mean= 26.9, SD=4.3), who was scanned twice on successive days at
every site for a total of 128 scans (8 subjects× 2 scans× 8 sites).
Scanning was conducted from May 4 through August 9 of 2011. There
were no equipment or software changes at any of these sites during this
period.
2.7. Assessment of reliability across scanners
Using the human traveling subjects data, variance components
analysis based on linear mixed-eﬀects modeling was performed to cal-
culate intra-class correlations (ICC) with restricted maximum likelihood
(REML) estimates. Given that the three factors (subject, site, occasion)
were fully crossed, the total variance of the dependent variable was
decomposed into the variance due to subject, site, occasion, subject-by-
site, subject-by-occasion, site-by-occasion, and subject-by-site-by occa-
sion, with each factor treated as a random eﬀect (Cannon et al., 2013;
Friedman et al., 2007). The model is as followed, with σ2 denoting the
variance of a dependent measure X for subject= i, site= j, and
visit= k. The residual variance is expected to represent a combination
of three-way interaction and residual error, with e denoting un-
explained variance due to error:
Two types of ICCs were computed: Between-site ICC (ICCBW) and
within-site ICC (ICCWI). ICCBW is measured by the fraction of variance
attributable to subject, reﬂecting reliability across sites and occasions.
ICCWI is measured by the fraction of variance attributable to subject
and site, reﬂecting reliability across scan occasions for the same subject
at the same site. The speciﬁc formulae used were:
= + + + + + +σ X σ σ σ σ σ σ σ i( )ijk i j k ij ik kj jk e2 2 2 2 2 2 2 2 ,
=
= + +
ICC σ σ
ICC σ σ σ σ
/
( )/
BW Subject Total
WI Subject Site Subject by Site Total
2 2
2 2 2 2
where σ2 refers to variance due to the factor(s) denoted by subscript.
This formulation of the within-site ICC produced results equivalent to
the test-retest ICC averaged across sites. ICCs can range from 0.0 to 1.0,
and results were interpreted according to the following recommenda-
tions: poor (below 0.40), fair (0.41–0.59), good (0.60–0.74), and ex-
cellent (above 0.75) (Cicchetti and Sparrow, 1981).
2.8. Premorbid adjustment scale
The premorbid adjustment scale (PAS) is one of the most commonly
used interview-based retrospective rating scales in schizophrenia for
assessing premorbid functioning (Cannon-Spoor et al., 1982; Van
Mastrigt and Addington, 2002). This scale assesses sociability and social
withdrawal, peer relationships, scholastic performance, adaptation to
school, and the ability to form socio-sexual relationships across four
diﬀerent developmental periods of development: childhood (age 5–11),
early adolescence (age 12–15), late adolescence (age 16–18), and
Y. Chung, et al. NeuroImage: Clinical 23 (2019) 101862
4
adulthood (age 19 and above) (Cannon-Spoor et al., 1982). As pre-
morbid functioning was deﬁned as the period preceding the onset of the
ﬁrst attenuated psychotic symptom that contributed to the participant
meeting COPS criteria, PAS ratings beyond the childhood period were
not applicable for CHR individuals in early adolescence (age 12–17)
(Lyngberg et al., 2015). Premorbid functioning was dichotomized into
“poor” and “good” functioning group, by using a cutoﬀ that is 1.5 SD
above the mean in the healthy control group (0.38 of the total PAS
score in childhood ranging from 0.0 to 1.0). Median PAS score in the
CHR group (PAS= 0.22) was also tested as an alternative way to deﬁne
the threshold.
2.9. Statistical analyses
Previous whole-brain analyses that contrasted individuals with at-
tenuated symptoms of psychosis (e.g., CHR, ARMS, psychosis spectrum
symptoms etc.) to healthy controls have mainly used the VBM method
and treated age as a covariate of non-interest to control for normative
neurodevelopmental eﬀects. In order to compare our results with other
independent studies, we adapted the previously used statistical models
as closely as possible and applied them to the NAPLS2 data. Statistical
whole-brain maps were generated and P values for comparisons be-
tween individuals at CHR and healthy controls were mapped at each
vertex. Linear mixed models were ﬁtted at each vertex across the sur-
face, with cortical volume, area, and thickness as dependent variables,
after partialing out the eﬀects of age, sex, and ICV. Scanner oﬀsets were
estimated as random eﬀects and adjusted using the linear mixed model
as proposed above. Z Monte Carlo simulations, one of the features
implemented for multiple comparison correction in FreeSurfer (Hagler,
Saygin, & Sereno, 2006; Hayasaka, 2003), was applied with a cluster-
forming threshold of P < .05 (two-sided). Uncorrected P values were
displayed within the thresholded clusters at P < .05.
For all group level analyses based on clinical outcome, a generalized
additive model (GAM) from the “mgcv” package in R Version 3.1.0.
[http://www.r-project.org/] was used to better characterize non-linear
trajectories of structural brain development. GAM ﬁtting has shown to
have some advantages over the use of polynomial models, as the shape
of the function does not have to be pre-deﬁned, and the placement of
Fig. 1. In the upper panels, mean cortical thickness of NAPLS2 healthy controls is plotted as a function of age before (upper left) and after (upper right) adjusting for
the scanner oﬀsets. The solid lines represent least-square linear ﬁts and the colors correspond to diﬀerent scanners used. In the lower panels, mean cortical thickness
of human traveler subjects are plotted across selected scanners. (Lower left) Mean cortical thickness before adjusting for scanner oﬀsets. (Lower right) Mean cortical
thickness after adjusting for the oﬀsets. Colors and shape correspond to human phantom ID and scan time points, respectively.
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the peaks of these polynomial ﬁts could be erroneously variable de-
pending on the age-range sampled for a study (Fjell et al., 2010).
Nonparametric smoothing splines were ﬁtted for the age term to allow
greater ﬂexibility without any restrictions on the shape of the curve.
Degree of smoothness was deﬁned using the thin plate regression spline
and was regularized based on restricted maximum likelihood to guard
against overﬁtting. Group status and other potential confounding
variables such as sex, maternal education, ethnicity and ICV were also
tested as conventional parametric linear terms. Signiﬁcance of the age
by group interaction term was tested with analysis of variance
(ANOVA) in the mgcv package.
Neuroanatomical measures for all subjects were transformed into Z
scores based on the means and standard deviations of the control group,
after partialing out variance associated with age, sex, ICV, and scanner
using the GAM ﬁtting method as described above. Study participants
were then partitioned into an early adolescent group (age range: 12–17)
and a later adolescent/young adult group (age range: 18–35). As eﬀect
sizes are expected to be modest and statistical power is signiﬁcantly
reduced due to partitioning the sample based on age, a series of sta-
tistical tests was performed in a hierarchical manner. First, the global
measures of cortical volume, cortical thickness, and surface area were
tested. If signiﬁcant association was detected at the global level, then
parcels from the Desikan atlas of both hemispheres were utilized to
examine regional speciﬁcity. False discovery rate (FDR) was set to 5%
for testing 68 ROIs (34 ROIs per hemisphere) per cortical index (i.e.
cortical thickness, surface area, cortical volume) to correct for multiple
comparisons (Benjamini and Hochberg, 2000). We did not implement
vertex-wise whole brain analysis for the partitioned sample by age, as
this method requires substantial statistical power to survive the strin-
gent correction for multiple comparisons that is imposed for testing all
vertices. Subcortical and ventricular volume measures (31 structures)
were also tested using the same approach (Fischl et al., 2002). This
strategy was also implemented when performing tests in relation to
antipsychotic medications and premorbid functioning.
For discerning regional neural correlates of clinical outcome within
the CHR individuals, we performed a priori hypothesis testing to reduce
the risk of being underpowered (false-negative). We predicted that
CHR-Converted/Decline group would show cortical deﬁcits in lateral
and medial prefrontal, parahippocampal, anterior cingulate, and su-
perior temporal regions relative to CHR-Stable/Remitted group, as
these regions were most frequently implicated in predicting clinical
outcomes among high-risk individuals (Borgwardt et al., 2007; Fusar-
Poli et al., 2011; Mechelli et al., 2011; Pantelis et al., 2003).
3. Results
3.1. Adjusting scanner-speciﬁc variance using age-related developmental
patterns
For nearly all of the neuroanatomical measures, ICCWI values were
in the excellent range (median=0.92, 1st quantile= 0.85, 3rd quan-
tile =0.96). Before correcting for scanner eﬀects, ICCBW values gen-
erally ranged from good to excellent for surface area, cortical volume,
and subcortical volume measures, while ICCBW values for cortical
thickness measures generally ranged from fair to good. However, when
cortical thickness measures were adjusted based on the random inter-
cept age regression parameters ﬁtted for scanner ID, the ICCBW values
generally improved towards good to excellent. As shown in the upper
panels of Fig. 1, mean cortical thickness as a function of age among
healthy controls is plotted for both before and after scanner correction
parameters were applied. Ordinary least square age regression ﬁts for
mean cortical thickness converged and the ICCBW improved from good
(ICCBW=0.68) to excellent (ICCBW=0.79). Descriptive statistics and
interpretations for the between-site ICCs are summarized in Table 2.
The frequency distribution of ICCBW values, for both raw and post-
scanner adjustment values, are shown in Fig. 2. Raw and adjusted ICCWI
and ICCBW values for all neuroanatomical ROIs evaluated are presented
in the supplementary materials. Scanner-corrected neuroanatomical
measures were used for all subsequent analyses.
3.2. Cortical gray matter deﬁcits in individuals at clinical high-risk
Based on GAM analysis, CHR individuals exhibited signiﬁcantly
smaller total cortical volume (t=−3.49, P < .001), total surface area
(t=−2.56, P= .012), and mean thickness (t=−3.34, P < .001)
compared with healthy controls (CHR: n=428, HC: n=205). A sig-
niﬁcant interaction between age and CHR status was observed for
cortical volume (P= .009) and surface area (P= .039), but the inter-
action term for cortical thickness did not reach signiﬁcance (P= .16).
Penalized regression splines were ﬁtted to each cortical measure as a
function of age and were visually inspected. As shown in Fig. 3, the 95%
conﬁdence intervals for GAM ﬁtted splines did not overlap among in-
dividuals between approximately 12 and 17 years of age. Signiﬁcantly
smaller cortical indices were observed among the CHR adolescents who
were under 18 years of age (volume: t=−3.90, P= .005; surface area:
t=−2.8, P= .018; thickness: t=−2.84, P= .016; CHR=197,
HC=68). There were no group diﬀerences among subjects who were
18 years of age or older (P values over 0.33).
In order to examine the spatial patterns of cortical deﬁcits in CHR
cases, vertex-wise whole brain analysis was conducted for each cortical
measure. As shown in Fig. 4, CHR individuals exhibited widespread,
signiﬁcantly smaller areas of cortical volume, surface area, and cortical
thickness relative to controls after correcting for multiple comparisons.
In terms of surface area, CHR individuals showed signiﬁcant reduction
in multiple brain areas including dorsolateral prefrontal, medial pre-
frontal, parahippocampal, fusiform area, and temporal regions. Re-
duced cortical thickness was observed in lateral occipital, pre- and post-
motor regions, parietal cortex, and temporal cortices. As cortical vo-
lume is a composite measure of thickness and area at each vertex, many
of the clusters with diminished cortical volume substantially over-
lapped with signiﬁcant clusters revealed in surface area and cortical
thickness maps.
3.3. Neuroanatomical correlates of clinical outcome in CHR individuals
In the younger adolescent group, CHR individuals with a remitted or
stable pattern of prodromal symptoms at follow-up (i.e. CHR-Stable/
Remitted) showed signiﬁcant reductions in cortical volume (t=−3.02,
P= .002) and cortical thickness (t=−2.39, P= .020) at baseline
compared with healthy controls (CHR-Stable/Remitted n=87, healthy
controls n=52; see Fig. 5; for regional speciﬁcity, see Table 3). CHR
cases who converted or had worsening symptoms (i.e., CHR-Converted/
Decline) exhibited reduced cortical volume (t=−4.04, P < .001),
surface area (t=−3.56, P= .0004, n=111), and cortical thickness
(t=−2.30, P= .027) compared with controls (CHR-Decline: n=59,
HC: n= 52; see Fig. 5; for regional speciﬁcity, see Table 4). There were
no signiﬁcant group diﬀerences on any of the neuroanatomical mea-
sures in the older group (Ps > 0.48). Group diﬀerences in the deep
brain structure and ventricular volume measures were not observed
across all age ranges (Ps > 0.28).
As we hypothesized from prior work, the CHR-Converted/Decline
group showed smaller surface area in rostral anterior cingulate, lateral
and medial prefrontal regions, and parahippocampal gyrus relative to
the CHR-Stable/Remitted group, among younger adolescents only
(CHR-Stable/Remitted: n= 87, CHR-Converted/Decline: n= 59; see
Table 5 for the list of ROIs). However, there were no signiﬁcant dif-
ferences in area of superior temporal gyrus and in any of the regional
cortical thickness measures. To supplement our results, we also per-
formed identical set of analyses to our cohort that is grouped into CHR-
C vs CHR-NC. The results are presented in the supplementary materials.
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3.4. Poor premorbid functioning is linked to structural brain abnormalities
in younger CHR adolescents
Finally, we tested whether neuroanatomical deﬁcits observed in
early adolescence were associated with poor premorbid functioning. As
shown in Fig. 6, younger subjects (CHR and healthy control subjects
combined; PAS good: n=111, poor: n= 87) with relatively poor
premorbid functioning showed smaller cortical volume (t=3.68,
P < .001) and surface area (t=2.88, P=0. 001), but no diﬀerence
was observed in cortical thickness (t=1.95, P= .062) than the good
premorbid functioning group; suggesting that the observed smaller
cortical volume is mainly driven by a smaller surface area. When group
Table 2
Descriptive statistics of between-site ICC across neuroanatomical measures before and after adjusting for scanner oﬀsets.
Type of neuroanatomical measurea Between-site ICCs for all ROIs
Median 1st quantile 3rd quantile Interpretationb
Raw Adjusted Raw Adjusted Raw Adjusted Raw Adjusted
Cortical thickness 0.63 0.69 0.51 0.60 0.73 0.77 Fair ~ Good Good ~ Excellent
Surface area 0.87 0.91 0.84 0.86 0.94 0.95 Excellent Excellent
Cortical volume 0.87 0.90 0.78 0.80 0.92 0.93 Excellent Excellent
Subcortical volume 0.84 0.86 0.71 0.74 0.92 0.94 Good ~ Excellent Good ~ Excellent
a Cortical parcellations (34 ROIs per hemisphere) were deﬁned using the Desikan atlas (Desikan et al., 2006). Selected deep brain structure volumes were derived
by automatic subcortical segmentation pipeline using Freesurfer (Fischl et al., 2002).
b Interpretations were made based on the range between 1st and 3rd quantiles.
Fig. 2. Frequency distribution of between-site ICCs both before and after adjusting for the scanner oﬀsets across all neuroanatomical Desikan based ROIs and
subcortical segmentations.
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diﬀerences were tested across all surface area ROIs, individuals with
poor premorbid functioning exhibited reductions in medial orbital
frontal, lateral frontal, rostral anterior cingulate, precuneus, and tem-
poral regions (See Table 6 for the complete list of ROIs). Smaller surface
area was associated with poor functioning even when median child-
hood PAS score in the CHR group (PAS=0.22) was used as a threshold
(t=4.19, P < .001), and also when the control subjects were excluded
from the analysis (see supplementary materials). Neuroanatomical
diﬀerences were not associated with PAS scores for the older group.
3.5. Antipsychotic medication exposure
Antipsychotic medication exposure at the time of baseline evalua-
tion did not correlate with the cortical measures among either the
younger CHR adolescents (cortical volume: F= 0.62, P= .43; surface
area: F= 0.20, P= .28; cortical thickness: F= 2.29, P= .13; n=121),
or the older CHR adolescents (cortical volume: F=0.12, P= .91; sur-
face area: F= 0.09, P= .76; cortical thickness: F= 1.53, P= .21,
n=261).
Fig. 3. GAM ﬁtted age trajectories of total cortical gray matter volume, surface area, and mean thickness for individuals at CHR (n=428) and healthy controls
(n=205). Shaded regions represent 95% conﬁdence interval.
Fig. 4. Statistical P-value maps showing clusters in which individuals at CHR (n=378) show signiﬁcantly smaller cortical volume, surface area, and cortical
thickness compared to healthy controls (n=190). Regions exhibiting smaller cortical measures in CHR individuals than healthy controls are represented with a
cooler color scheme. The eﬀect was corrected for multiple comparisons by z Monte Carlo simulations and thresholded at P < .05. Uncorrected P values were
displayed within the thresholded clusters.
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4. Discussion
Widespread cortical deﬁciencies were predominantly observed
among CHR individuals who were ascertained between 12 and 17 years
of age compared to healthy controls at baseline evaluation. In contrast,
group diﬀerences in the cortical measures were not observed among
those who were 18 years of age or older. In terms of regional speciﬁcity
for the younger group, vertex-wise between-group analysis revealed
reduced cortical volume in dorsal lateral and medial prefrontal cortex,
inferior parietal, parahippocampal, fusiform and inferior temporal re-
gions, which resembles the spatial distribution of cortical deﬁcits in
multiple early disease stages of psychosis (Borgwardt et al., 2007;
Fusar-Poli et al., 2011; Mechelli et al., 2011; Pantelis et al., 2003, 2005;
Satterthwaite et al., 2016). Evidence of cortical volume loss in the CHR
sample were further explained by a diﬀerential regional pattern of
smaller cortical thickness and surface area. Given that cortical volume
is a composite index reﬂecting both cortical thickness and surface area
at each vertex, diminished cortical volume in dorsal lateral prefrontal,
medio-orbital frontal, parahippocampal gyrus, and inferior parietal and
temporal cortices were primarily driven by smaller surface area, while
alterations in cortical thickness better explained cortical volume loss in
pre- and post-central regions, precuneus, inferior temporal cortex, and
lateral occipital cortex.
Aligned with our ﬁndings, youth with attenuated psychosis spec-
trum symptoms in the Philadelphia Neurodevelopmental Cohort (PNC)
also showed reduced gray matter volume in similar brain regions in-
cluding medial and orbital frontal cortex, dorsal lateral prefrontal
cortex, precuneus, parahippocampal, and fusiform areas (Satterthwaite
et al., 2016). Modest discrepancies in the results may be due to dif-
ferences in the strategy of recruitment (community-based vs help-
seeking), methodological diﬀerences in image processing, and demo-
graphic diﬀerences (age range). Nevertheless, given that both PNC and
the NAPLS2 datasets have comparable sample size with an age range
that encompasses early to mid-teenage years, the considerable overlap
in regions showing cortical deﬁcits in both cohort studies demonstrate
manifestations of cortical abnormalities among individuals with atte-
nuated symptoms of psychosis, especially among those who were as-
certained in early adolescence.
We further investigated whether neuroanatomical deviance in early
adolescence at the time of baseline evaluation is predictive of clinical
outcome. While both better (CHR-Stable/Remitted) and poorer (CHR-
Converted/Decline) clinical outcome group showed signiﬁcant reduc-
tion in cortical indices compared to the healthy controls, regardless of
their clinical outcome, the eﬀect sizes of the poorer clinical outcome
group were generally larger relative to the better outcome group.
Within the CHR individuals, the group with poorer clinical outcomes
showed signiﬁcantly reduced surface area in superior, medial, and
lateral prefrontal regions, rostral anterior cingulate, and para-
hippocampal gyrus compared with the better outcome group. This re-
gional pattern is consistent with previous ﬁndings from at least two
VBM studies, which have also reported gray matter volume loss in these
brain regions among high-risk individuals who later developed psy-
chosis compared with those who did not (Mechelli et al., 2011; Pantelis
et al., 2003). Performing a surface-based analysis in the present study
further revealed that the volumetric diﬀerences from previous studies
might be driven by surface areal deﬁcits and that this neuroanatomical
proﬁle might underlie insidious onset form of psychosis. Given that
CHR individuals in both poorer and better outcome groups show cor-
tical abnormalities, it does not appear that there is a critical threshold
Fig. 5. Diﬀerences in cortex volume, surface area, and cortical thickness be-
tween CHR-Stable/Remitted (n=87), CHR-Decline (n=59), and healthy
controls (n=52) who are 17 years of age or under. P-values for post-hoc
pairwise t-tests are indicated (uncorrected). *P < .05, **P < .01 ***
P < .001.
Table 3
Between-group t-tests of CHR-Stable/Remitted (n=87) versus healthy controls
(n=52) among subjects 17 years of age and under.
CHR-Stable/Remitted vs Healthy Control
Hemisphere ROI Cohen's D Uncorrected
P-value
FDR
Corrected
P-value
Cortical thickness
Right Supramarginal −0.52 0.005 0.094
Postcentral −0.48 0.005 0.094
Posterior Cingulate −0.44 0.017 0.13
Superior Parietal −0.41 0.017 0.15
Inferior Parietal −0.36 0.047 0.16
Left Superior Temporal −0.50 0.005 0.094
Entorhinal −0.52 0.005 0.094
Supramarginal −0.51 0.007 0.094
Postcentral −0.45 0.011 0.10
Lateral Occiptal −0.42 0.017 0.13
Middle Temporal −0.42 0.022 0.15
Precuneus −0.38 0.037 0.16
Surface area
Right Medial Orbital Frontal −0.47 0.008 0.15
Insula −0.45 0.008 0.15
Superior Temporal −0.35 0.044 0.32
Caudal Anterior
Cingulate
−0.34 0.047 0.32
Left Middle Temporal −0.62 < 0.001 0.036
Inferior Temporal −0.50 0.006 0.15
Caudal Anterior
Cingulate
−0.41 0.016 0.21
Medial Orbital Frontal −0.35 0.04 0.32
Cortical volume
Right Medial Orbital Frontal −0.54 0.0031 0.066
Paracentral −0.46 0.004 0.066
Superior Temporal −0.46 0.008 0.11
Insula −0.43 0.014 0.11
Postcentral −0.42 0.015 0.11
Precuneus −0.43 0.022 0.12
Fusiform −0.39 0.023 0.12
Inferior Parietal −0.37 0.031 0.14
Left Middle Temporal −0.61 0.0007 0.051
Caudal Anterior
Cingulate
−0.50 0.004 0.065
Inferior Temporal −0.48 0.012 0.11
Postcentral −0.44 0.012 0.11
Entorhinal −0.41 0.017 0.12
Precuneus −0.43 0.020 0.12
Fusiform −0.40 0.030 0.14
Superior Temporal −0.35 0.042 0.17
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that could reliability determine outcome in terms of a discrete con-
struct, hence the preexisting neuroanatomical deviance as a marker of
vulnerability for psychosis should be best regarded as a continuum.
Reduced surface area in superior and medial frontal cortex, pre-
cuneus, rostral anterior cingulate, and temporal regions among in-
dividuals in early adolescence were associated with poorer premorbid
functioning in childhood. Interestingly, reduced surface area in many of
these overlapping regions were also predictive of poorer clinical out-
come. As the cerebral cortex undergoes rapid surface areal expansion
and folding during the pre and peri-natal period, disturbances during
early brain development could exert persisting eﬀects on the dynamic
cascade of post-natal brain maturation (Raznahan et al., 2012; Rees and
Inder, 2005; Smith et al., 2015; Walhovd et al., 2012). Support for this
view was observed in that normative variation of birth weight, which is
a widely used proxy indicator of perinatal health, was robustly asso-
ciated with surface area in widespread brain regions in typically de-
veloping individuals (Raznahan et al., 2012; Walhovd et al., 2012). In
the context of schizophrenia, adult patients with history of obstetric
complications such as intra-uterine growth retardation (IUGR) or fetal
hypoxia manifested greater structural brain abnormalities (Cannon
et al., 2002; van Erp et al., 2002). In particular, recent studies suggest
that previously reported gray matter volumetric diﬀerences associated
with obstetric complications among schizophrenia patients is better
explained by smaller cortical surface area, rather than cortical thickness
(Haukvik et al., 2009; Smith et al., 2015). Therefore, although we do
not have prospective information of early life risk factors, such as ob-
jective records of obstetric history, for the NAPLS2 sample, it is plau-
sible based on the prior literature that alterations in surface area among
younger CHR adolescents may reﬂect manifestations of early neuro-
developmental insults. The mechanism behind the speciﬁcity of surface
area deﬁcits, which are predominantly observed in heteromodal asso-
ciation regions, is unclear; in the context of brain development, it could
be that the developmental processes in phylogenically newer areas
(higher-ordered association cortices) are more vulnerable to early life
disturbances than the older regions (lower-order somatosensory and
visual cortices) or it could be that neural insults speciﬁc to these regions
Table 4
Between group t-tests of CHR-Converted/Decline (n=59) versus healthy
controls (n=52) among subjects 17 years of age and under.
CHR-Converted/Decline vs Healthy Control
Hemisphere ROI Cohen's D Uncorrected
P-value
FDR
Corrected
P-value
Cortical thickness
Right Banks of Sup. Temporal
Sulcus
−0.67 < 0.001 0.030
Supramarginal −0.65 0.001 0.030
Caudal Middle Frontal −0.54 0.006 0.081
Inferior Parietal −0.50 0.01 0.085
Superior Parietal −0.47 0.015 0.11
Post Central −0.46 0.015 0.11
Cuneus −0.44 0.021 0.12
Superior Temporal −0.42 0.029 0.15
Pre Central −0.37 0.047 0.19
Left Superior Temporal −0.65 0.001 0.030
Middle Temporal −0.57 0.004 0.071
Inferior Temporal −0.52 0.007 0.081
Superior Parietal −0.51 0.008 0.081
Supra Marginal −0.46 0.017 0.11
Post Central −0.49 0.037 0.18
Superior Frontal −0.40 0.040 0.18
Lateral Occipital −0.40 0.047 0.18
Surface area
Right Rostral Anterior
Cingulate
−0.62 0.001 0.026
Superior Frontal −0.61 0.002 0.026
Superior Temporal −0.60 0.002 0.026
Insula −0.57 0.003 0.038
Medial Orbito Frontal −0.53 0.006 0.053
Post Central −0.49 0.011 0.069
Fusiform −0.48 0.014 0.085
Caudal Anterior
Cingulate
−0.45 0.019 0.088
Middle Temporal −0.44 0.021 0.088
Rostral Middle Frontal −0.42 0.026 0.10
Paracentral −0.41 0.029 0.11
Inferior Temporal −0.41 0.020 0.12
Left Rostral Middle Frontal −0.75 < 0.001 0.005
Middle Temporal −0.75 < 0.001 0.004
Fusiform −0.55 0.005 0.049
Parahippocampal −0.50 0.009 0.069
Superior Frontal −0.49 0.011 0.069
Inferior Temporal −0.46 0.019 0.089
Banks of Superior
Temporal Sulcus
−0.45 0.019 0.089
Cortical volume
Right Superior Temporal −0.71 < 0.001 0.010
Post Central −0.68 < 0.001 0.010
Banks of Superior
Temporal Sulcus
−0.67 < 0.001 0.011
Rostral Anterior
Cingulate
−0.64 0.001 0.014
Insula −0.61 0.002 0.018
Superior Frontal −0.59 0.002 0.019
Medial Orbito Frontal −0.53 0.006 0.035
Paracentral −0.50 0.007 0.035
Inferior Parietal −0.51 0.007 0.035
Caudal Anterior
Cingulate
−0.48 0.013 0.054
Middle Temporal −0.48 0.013 0.054
Cuneus −0.45 0.018 0.067
Fusiform −0.43 0.026 0.091
Precentral −0.38 0.047 0.13
Table 4 (continued)
CHR-Converted/Decline vs Healthy Control
Hemisphere ROI Cohen's D Uncorrected
P-value
FDR
Corrected
P-value
Left Middle Temporal −0.78 <0.001 0.006
Superior Temporal −0.62 0.001 0.014
Rostral Middle Frontal −0.58 0.002 0.021
Inferior Temporal −0.56 0.005 0.030
Banks of Superior
Temporal Sulcus
−0.54 0.005 0.032
Superior Frontal −0.53 0.006 0.033
Post Central −0.47 0.019 0.061
Fusiform −0.42 0.029 0.094
Paracentral −0.38 0.048 0.12
Rostral Anterior
Cingulate
−0.39 0.048 0.12
Table 5
Between group t-tests of CHR-Stable/Remitted (n= 87) versus CHR-
Converted/Decline (n= 59) among subjects 17 years of age and under.
CHR-Converted/Decline vs CHR-Stable/Remitted
Hemisphere ROI Cohen's D P-value
Right Superior Frontal −0.41 0.013
Rosterior Anterior Cingulate −0.34 0.034
Left Rostral Middle Frontal −0.41 0.014
Parahippocampal −0.42 0.015
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during early brain development become a risk factor for psychosis (as
opposed to other kinds of neuropsychiatric outcomes).
Conversely, cortical thickness was not associated with premorbid
functioning, suggesting that developmental factors that shape cortical
thickness may be less sensitive to early life risk factors. Alterations in
cortical thickness measures in younger CHR adolescents were generally
observed in primary motor, sensory or in the posterior regions; parts of
the brain that have been identiﬁed to mature earlier than higher order
association areas in structural brain MRI measures (Gogtay et al., 2004;
Tamnes et al., 2017). Non-linear monotonic decrease in cortical thick-
ness that extends from childhood to early adulthood is thought to be a
composite signal of numerous normal neuromaturational processes
such as synaptic pruning, dendritic retraction and intracortical myeli-
nation (Catts et al., 2013; Huttenlocher, 1979; Huttenlocher and
Dabholkar, 1997; Walhovd et al., 2016). In reﬂection of these normal
brain maturational events, the rate of cortical thinning in the unimodal
and the posterior regions reaches its peak in childhood, whereas cor-
tical thinning in the associative and anterior regions typically extends
through mid to late adolescence. Given that the spatiotemporal se-
quences of the cortical maturational pattern are highly regularized,
reduced cortical thickness in the lower-order cortices in relation to
psychosis risk may be a result of abnormal neuromaturational events or
a disease process that co-occurs in the order in which these regions
mature (i.e. starting with lower ordered posterior regions and con-
tinuing up to anterior associative regions). As another possibility, en-
vironmental risk factors, such as childhood trauma or drug abuse in-
teracting with high genetic loading of schizophrenia, may have
contributed to the alterations in cortical thickness (Habets et al., 2011).
Nevertheless, further work is needed to replicate this pattern of ﬁndings
and to clarify these interpretations.
In our previous work, brain age deviation score (i.e. brain age gap)
did not correlate with premorbid functioning (Chung et al., 2018). This
may be due to the fact that the version of the brain age model that we
used considers diﬀerent aspects of brain morphometry simultaneously
(i.e., surface area, cortical thickness, subcortical volume) to predict
chronological age, whereas premorbid functioning was speciﬁcally as-
sociated with surface area measures only, but not with cortical thick-
ness. Given our interpretations that diﬀerential patterns of alterations
in cortical thickness and surface area reﬂect heterogeneity in the
etiology of neurodevelopmental disturbances, our ﬁndings suggest that
the brain age metric is useful for quantifying gross deviation from
normal developmental pattern of neuroanatomical changes at an in-
dividual subject level, but lacks sensitivity for detecting distinct pat-
terns of neuroanatomical deviance that confers risk for psychosis.
Signs of neuroanatomical compromise were not observed among
CHR individuals who were ascertained at 18 years of age or later. The
null ﬁndings of cortical deﬁcits between the groups could be explained
by better sensitivity of CHR criteria in recruiting acute-onset forms of
psychosis in late adolescence or early adulthood who are expected to be
neuroanatomically similar to typically developing age-matched peers
throughout most of the premorbid period but show a rapidly increasing
deviation prior to the onset of psychosis (Cannon et al., 2015; Chung
et al., 2018). Also, CHR individuals with more insidious onset who
might show greater manifestations of pre-existing brain abnormalities
are likely to be underrepresented among in the older group as they are
more likely convert to psychosis before reaching late adolescence.
Our evaluation of the between-scanner reliabilities using the human
traveling subject data indicate that raw ROI measures of surface area
and subcortical volume were mostly in the good to superior range. In
contrast, between-site reliabilities for cortical volume and cortical
thickness measures were relatively modest. In this study, we adjusted
for the scanner oﬀsets based on prior knowledge in the literature that
the shapes (or slopes) of growth curves of cortical measures in typically
developing individuals are generalizable across independent datasets
(Tamnes et al., 2017); this pattern was also observed in our dataset in
which age regression slopes for each scanner were markedly parallel to
each other. In this study, we showed that the scanner related adjust-
ment we made improved between-site reliabilities of cortical thickness
measures from mostly in the fair to good range into good to excellent
range. A clear advantage of this approach is that the scanner related
variance could be further reduced at post-hoc as long as there was
suﬃcient sample size of healthy controls assessed at each scanner to
reproduce the age related slope and intercept estimates.
There are some limitations to this study. Age at ascertainment is not
an optimal measure for estimating age at prodromal symptom onset, as
it does not consider the recency of when the symptoms emerged. This
makes it diﬃcult to model developmental trajectories of neuroanato-
mical structures as a function of age at onset. However, determining the
age when prodromal symptoms ﬁrst emerged is challenging as clin-
icians have to rely on subjects' retrospective memory to identify subtle
symptoms that are linked to psychosis. Similarly, PAS also relies on
retrospective memory; hence recalling the level of functioning during
childhood is susceptible to bias, especially for the older participants as
they have to recall more distant memories. Also, additional
Fig. 6. Diﬀerences in cortex volume, surface area, and cortical thickness be-
tween individuals with poor (n=87) versus good (n=111) premorbid func-
tioning among those who are 17 years of age or under (CHR and control in-
dividuals combined). P-values for post-hoc pairwise t-tests are indicated
(uncorrected). **P < .01 *** P < .001.
Table 6
Between group t-tests of PAS Good (n= 111) vs Poor (n=87) among subjects
17 years of age and under.
PAS Good vs CHR-Poor
Hemisphere ROI t Uncorrected
P-value
FDR Corrected
P-value
Surface area
Right Medial Orbito Frontal 3.37 0.0009 0.015
Banks of Sup. Temporal
Sulcus
2.82 0.0008 0.045
Rostral Anterior Cingulate 2.76 0.005 0.045
Precuneus 2.74 0.006 0.045
Left Precuneus 3.78 0.0002 0.014
Inferior Temporal 3.58 0.0004 0.014
Middle Temporal 3.38 0.0008 0.015
Rostral Middle Frontal 3.19 0.0017 0.023
Fusiform 2.96 0.0034 0.038
Superior Frontal 2.86 0.0063 0.045
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investigation is required to conﬁrm whether neuroanatomical ab-
normalities observed among the younger CHR cases are indeed linked
to exposure to early neurodevelopmental risk factors (e.g., obstetric
complications) as objective medical records of birth complications were
not available for this sample. Prospective longitudinal birth cohort
studies that are population-based or oversampled for psychosis risk
with objective records (e.g., medical records, diary, video recordings,
periodic psychological evaluation etc.) could address these limitations
and further clarify the relationship between early life risk factors and
developmental trajectories associated with onset of psychosis at dif-
ferent ages.
5. Conclusion
The novel contribution of this study is that deviance in neuroana-
tomical measures from normal developmental trajectories is pre-
dominantly observed in younger CHR individuals who present with an
insidious onset pattern of psychosis. These early-manifesting cortical
alterations overlap with brain regions that have previously been linked
to schizophrenia and are associated with worsening clinical outcome in
this sample. Based on this evidence, it would seem overly simplistic and
highly misleading to view individuals experiencing attenuated symp-
toms of psychosis as a homogenous group with respect to variation in
neuroanatomical structures (e.g., Fig. 3). Instead, variation in neuroa-
natomical measures must be considered with respect to the age of the
individuals at the time of ascertainment for a psychosis risk syndrome,
which in turn likely reﬂects heterogeneity in exposure to early risk
factors and premorbid course. CHR individuals with poor premorbid
functioning in childhood and earlier ages of prodromal symptom onset
are expected to exhibit greater neuroanatomical deviation relative to
age-matched peers prior to onset of psychosis. This interpretation
suggests that structural brain measures assessed at baseline are likely to
be sensitive primarily to “insidious” or “early” onset forms of psychosis
among individuals at CHR. Nonetheless, this age moderated pattern
needs to be replicated in independent datasets to conﬁrm the general-
izability of our ﬁndings. In addition, future work is encouraged to in-
vestigate whether the neuroanatomical proﬁle linked to “early onset”
forms of psychosis increase likelihood for experiencing later neuroma-
turational disturbances (e.g. disrupted synaptic pruning) once they
become older adolescents.
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